Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
S••••• C•••••• M••••••••• L•••
S••••• Capital is a healthcare investment firm that is primarily focused on the innovative areas of life sciences, including biotech and medtech.
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 5 of 7 distinct vehicles are sworn Private Equity Funds; 5 reported gross assets on a filing in 2022 or later
- Size band
- Lower middle marketdefined by: proxy: $0.41bn Private Equity Fund GAV on the Form ADV filed 2024-07-03
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 5 of 7 distinct vehicles are sworn P•••••• Equity Funds; 5 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Mar 28, 2018 to Jul 3, 2024
- RAUM
- $2.0Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 4
- PE fund GAV, latest filing
- $410Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $2.0Bevery private fund type, latest filing
- 2024 PE fund GAV
- $410Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 71%
- Fund type mix
- filed 2024-07-03, latest gav Hedge Fund $1.6B, Private Equity Fund $410M, latest counts Hedge Fund 2, Private Equity Fund 4, lifetime distinct Hedge Fund 2, Private Equity Fund 5
- Employees
- 17
- Headquarters
- Greenwich, CT
- Office address
- 104 FIELD POINT ROAD, 2ND FLOOR, Greenwich, CT, 06830
- Business phone
- 475-208-3178
- Sectors
- healthcare, life sciences
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- We invest across the healthcare lifecycle from developmental-stage companies through commercial companies.
- roles
- minority 2
- period
- to 2026-08-12, from 2026-07-22, undated holdings 0, dated observations 2
- window
- last unknown, first unknown
- control
- minority 2
- companies
- 2
- geography
- count 1, share unknown, value IL
- investments
- 2
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 1
- disclosed value usd
- n 0
- sector distribution
- count 1, share unknown, value life sciences, examples Bridge to Life Ltd
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 1, share unknown, value medical devices, examples Bridge to Life Ltd
2 companies on the graph (0 transactions); most in life sciences (1); observed 2026 to 2026
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| S••••• P•••••• E••••• F••• I••• L••• ADV: P•••••• Equity Fund | Buyout fund | 2023 first reported on Form ADV | $195M as of Jul 3, 2024 | no Form D | Early deployment | |
| S••••• P•••••• E••••• F••• I•• L••• ADV: P•••••• Equity Fund | Buyout fund | 2022 first reported on Form ADV | $181M as of Jul 3, 2024 | no Form D | Early deployment | |
| S••••• B• S••• L•• ADV: P•••••• Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $94,051 as of Mar 15, 2023 | no Form D | Wound down | |
| S••••• B• S••• L•• ADV: P•••••• Equity Fund | buyout or unlabelled | 2020 first reported on Form ADV | $8.5M as of Jul 3, 2024 | no Form D | Active deployment | |
| S••••• P•••••• E••••• F••• I• L••• ADV: P•••••• Equity Fund | Buyout fund | 2018 first reported on Form ADV | $25.3M as of Jul 3, 2024 | no Form D | Harvest |
- B••••••• A••••• L••• · Limited Partner · since Jan 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- C•••••• A••••• D•••• · Member · since Sep 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- D•••• A•••• C••••• · Limited Partner · since Apr 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- G•• B• L••• · Sole Owner · since Dec 1, 2017 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- S•••••• N•• F••••••• · Member · since Sep 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- H••••• J•••• S•••••• · General Counsel; Chief Compliance Officer · since Jun 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- M•••••• A•••••• C•••••• · Chief Financial Officer · since May 1, 2021 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- S••••• J• M••••••• · Chief Operating Officer; Limited Partner · since Feb 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
3 former (kept with end dates)
- N•••• L••• · Trustee Of Guy L••• 2018 Gst Tr · Sep 1, 2018 to Jul 3, 2024 Inference
- B•••••• L••••• K••••• · Limited Partner · Jan 1, 2019 to Mar 15, 2023 Inference
- Z•••••• T•••• W••••••• · Limited Partner · Apr 1, 2022 to Mar 26, 2024 Inference
| Company | Role | Status | Invested | Held | Partner | Source |
|---|---|---|---|---|---|---|
| B••••• t• L••• L•• | Minority | active | Aug 12, 2026 venture round | 1 months | unknown | Fact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe) |
| C•••••••• T••••••••• | Minority | active | Jul 22, 2026 venture round | 2 months | unknown | Fact DFX graph bridge (shared CRD, CIK, EIN, SEC fund id and individual CRD across fo/isi/vc/pe) |
- J•••••••• L•• 1 shared · one time · last Jan 1, 2024
- T•• S••••••••• I••• 1 shared · one time · last Jan 1, 2023
- A•••• C•••••• A••••••• L••• 1 shared · one time · last Jan 1, 2023
- Apr 27, 2026S••••• C•••••• M••••••••• L•••: P•••••• Equity Funds on Form ADV 4 (2024 extract) -> 11 (roster 2026-09-01)
- Mar 28, 2018S••••• C•••••• M••••••••• L••• first filed Form ADV in the extract (IA)
S••••• C•••••• M••••••••• L••• is the same institution as 3 records in Venture Capital, Independent Sponsors and RIA and Wealth.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…